- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05471466
Scar Outcomes for Scalpel Versus Diathermy Neck Incisions in an Afro-Caribbean Population
July 20, 2022 updated by: CeLois Lawrence
Scar Outcomes for Scalpel Versus Diathermy Neck Incisions in an Afro-Caribbean Population: A Randomized Controlled Trial
This is randomized controlled double-blinded trial comparing the scar outcomes of diathermy versus scalpel surgical incisions in the neck.
It was conducted in humans in an Afro-Caribbean (black) population.
Study Overview
Detailed Description
This double-blinded parallel group randomized controlled trial included consecutive eligible Ear, Nose and Throat (ENT) patients at a Jamaican tertiary hospital requiring an anterior neck incision.
The purpose was to determine whether cutting diathermy adversely affected scar cosmesis in an Afro-Caribbean population and whether complexion influenced this outcome.
Half of the incision in each of 35 patients was randomly assigned to either cutting electrocautery or scalpel.
The patients and the assessor of the scars were blinded and the both sides of the scar were assessed by both parties using the patient component of the Patient and Observer Scar Assessment Score (PSAS) and the Vancouver Scar Scale (VSS) at 1 week, 3 months and 6 months postoperative intervals.
The Fitzpatrick Phototyping Scale was used for skin pigmentation classification.
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kingston, Jamaica
- Kingston Public Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
The following are the conditions for inclusion in the study:
- Subjects must be 18 years of age or older and give written informed consent
- Treatment for surgical condition requires the type of neck incision that would be used for a standard thyroidectomy i.e. a horizontal incision about 2 fingers' breadth above the sternal notch or in a skin crease close to that landmark extending from the anterior border of one sternocleidomastoid muscle to another.
- Only elective surgical cases will be included
- Only primary incisions will be included i.e. no completion thyroidectomies or scar revisions to the neck
- Only clean surgeries will be included
- All wounds must be closed primarily i.e. no wounds healed by secondary intention or delayed primary closure or flap or graft coverage will be included
Exclusion Criteria:
The following are conditions for exclusion from the study:
- Subjects with skin pathologies i.e. patients with dermatological conditions, skin infections, altered pigmentation to the neck, use of skin-lightening agents to the neck, or neurofibromatosis will be excluded.
- Surgeries requiring a drain (This is a relative exclusion criterion as subjects with drains that are pulled through skin outside of the incision site may be included. However, patient must consent to this prior).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Diathermy- Electrosurgical Unit Cutting Settings
One half of the neck incision in each participant was made using diathermy (electrosurgical unit cutting settings at 15 watts Blend One mode).
|
Surgical incisions to the neck as part of the management of the head and neck condition.
|
|
ACTIVE_COMPARATOR: Scalpel- Surgical Blade
One half of the neck incision in each participant was made using a scalpel (size 10 surgical blade).
|
Surgical incisions to the neck as part of the management of the head and neck condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference between diathermy and scalpel scar cosmesis- Total PSAS.
Time Frame: Six months
|
Difference in scar cosmesis between the diathermy and scalpel sides of the scar as assesses by the Total Patient Scar Assessment Score (PSAS) on a scale of 6 to 60 where 6 is as per normal skin and 60 is very different from normal skin.
There were measured at 1 week, 3 months, and 6 months post-surgery.
|
Six months
|
|
Difference between diathermy and scalpel scar cosmesis- Overall PSAS.
Time Frame: Six months
|
Difference in scar cosmesis between the diathermy and scalpel sides of the scar as assesses by the Overall Patient Scar Assessment Score (PSAS) on a scale of 1 to 10 where 1 is as per normal skin and 10 is very different from normal skin.
These were measured at 1 week, 3 months, and 6 months post-surgery.
|
Six months
|
|
Difference between diathermy and scalpel scar cosmesis- VSS.
Time Frame: Six months
|
Difference in scar cosmesis between the diathermy and scalpel sides of the scar as assesses by the Vancouver Scar Scale (VSS) on a scale of 0 to 13 where 0 is as per normal skin and 13 is the most extreme difference from normal skin.
These were measured at 1 week, 3 months, and 6 months post-surgery.
|
Six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in scar cosmesis based on skin complexion.
Time Frame: Six months
|
Difference in scar cosmesis based on Fitzpatrick Phototyping category (skin complexion) on a scale of 1 to 6 where 1 is the lightest skin complexion and 6 is the darkest.
This is as per the Total Patient Scar Assessment Score (PSAS), Overall PSAS and the Vancouver Scar Scale (VSS) measured at 1 week, 3 months, and 6 months post-surgery.
|
Six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: CeLois Lawrence, BSc MBBS, Kingston Public Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 21, 2019
Primary Completion (ACTUAL)
January 25, 2021
Study Completion (ACTUAL)
January 25, 2021
Study Registration Dates
First Submitted
July 14, 2022
First Submitted That Met QC Criteria
July 20, 2022
First Posted (ACTUAL)
July 22, 2022
Study Record Updates
Last Update Posted (ACTUAL)
July 22, 2022
Last Update Submitted That Met QC Criteria
July 20, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1 (Mobile Health and Wellness Program)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individual patient data directly related to the research outcomes in the publication will be shared upon request.
IPD Sharing Time Frame
The data will become available up to 2 years after the date of publication/ journal issue.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Incision
-
Near East University, TurkeyCompletedCesarean Delivery Affecting Fetus | Incision, Surgical | Pfannenstiel Incision Length | Fetal Occipitofrontal DiameterTurkey
-
Molnlycke Health Care ABSyntactxNot yet recruitingSurgical Wound | Surgical Incision | Surgical Wound Dehiscence | Incision, Surgical | Surgical Wound, Recent
-
Diskapi Teaching and Research HospitalCompleted
-
Sarasota Memorial Health Care SystemMiMedx Group, Inc.Enrolling by invitationParathyroid Diseases | Surgical Incision | Incision | Thyroid; WoundUnited States
-
Columbia UniversityEthicon, Inc.CompletedEfficiency of Surgical Incision Closure | Post-operative ScarUnited States
-
The Metis FoundationCompletedIncisions, SurgicalUnited States
-
Stony Brook UniversityWithdrawn
-
Ethicon, Inc.CompletedSurgical IncisionsBelgium, Germany, Sweden, United Kingdom
-
The University of Texas Health Science Center,...CompletedObesity | Incision, SurgicalUnited States
-
Inonu UniversityCompletedSurgical IncisionTurkey
Clinical Trials on Surgical incision
-
Fujian Medical University Union HospitalRecruitingSurgical Incision | Minimally Invasive SurgeryChina
-
Hasan Kalyoncu UniversityRecruiting
-
Diskapi Yildirim Beyazit Education and Research...Unknown
-
Universidad de MurciaRecruitingPeriodontitis | Periodontal Diseases | Periodontal PocketSpain
-
University of Missouri-ColumbiaCompletedInfection, BacterialUnited States
-
Aatru Medical LLCNAMSACompleted
-
willner nadav MDRecruitingSevere Aortic Valve Disease | Small Aortic Annulus | Aortic Valve Replacement (AVR)Israel
-
University Hospitals Cleveland Medical CenterNot yet recruitingCurrent OBGYN Attending, Resident, or Fellow at University HospitalsUnited States
-
KCI USA, IncTerminatedSurgical Site ReactionUnited States
-
Johns Hopkins UniversityCompletedPancreatic Neoplasms | Pancreatic Cancer | Chemoradiation | Surgical Wound | Surgical Site Infection | Wound Complication | Chemotherapy EffectsUnited States